Biocon Ltd.

BIOCON

Market Cap
₹37,405 Cr.
P/E
31.17

Biocon Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
2.59%
3yr Average
6.66%
5yr Average
9.2%
Net Profit Margin
Latest
4.14%
3yr Average
7.48%
5yr Average
10.14%
ROCE
Latest
4.1%
3yr Average
7.01%
5yr Average
9.08%
Debt to Equity
Latest
0.99
3yr Average
0.72
5yr Average
0.59
Market Share
1.52% (as of Jul 22)
Anti - Diabetes - Market Share
0.27% (as of Jul 22)
Anti-Infectives - Market Share
4.21% (as of Nov 21)
Antineo Plastic - Market Share
1.04% (as of Nov 21)
Blood Related - Market Share
27% (as of Mar 19)
CANMAb - Market Share
locked Source
0.05% (as of Jul 22)
Cardiovascular - Market Share
0.16% (as of Nov 21)
Dermatology - Market Share
0.04% (as of Apr 20)
Endocrinology - Market Share
0.01% (as of Jul 22)
Gastro-Intestinal - Market Share
75% (as of Mar 19)
Insugen - Market Share
locked Source
50% (as of Mar 19)
Orlistat API - Market Share
locked Source
0.01% (as of Nov 21)
Pain - Market Share
21% (as of Mar 19)
Pegfi Igrastim Syringes - Market Sharee
locked Source
0.30% (as of Dec 22)
Pharmaceutical Sector - Market Share
30% (as of Mar 20)
Trastuzumab - Market Share
locked Source
0.15% (as of Jul 22)
Vaccines - Market Share
0% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Operating Profit Break-Up

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    CANMAb
    Insugen
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Biocon Ltd.
    Biocon Biologics Serum Lifesciences collaboration call notes - JST Investments
    View the discussion on ValuePickr
    Industrial Biotechnology - Insulin Production - NPTEL
    How Biocon produces Insulin using rDNA Technology - Bio Science
    Biocon - Viatris Takeover Primer - JST Investments
    Biocon Biologics - An effort to understand the biosimilar business - Dr Midhun
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline